Molecular and Cellular Basis of Disease (MCBD)

Cell InjuryCell Injury

AdaptedCell

+ Stress

Injury

Normal cell

Reversibly injured cell

Irreversibly Injured cell

Dead cell

+Stress

Apoptosis

Necrosis

- Stress

- Stress

Overview

AdaptedCell

+ StressNormal cell

- Stress

Cellular adaptation

AdaptedCell

+StressNormal cell

Stress = ?

Increased/decreased workload* skeletal muscle and body building

* cardiac muscle and hypertension

* skeletal muscle disuse (limb immobilization)

Increased/decreased stimulation* estrogenic stimulation of uterus in pregnancy

* estrogen/prolactin stimulation of breast (lactation)

* denervation of muscle

- Stress

AdaptedCell

Cellular adaptations to stress

1. Hyperplasia (more cells)

2. Hypertrophy (bigger cells)

3. Atrophy (smaller cells)

4. Metaplasia (different type of cells)

1. Hyperplasia1. Hyperplasia(more cells)(more cells)

1. Physiologic1. Physiologic

* Hormonal (breast/uterus in pregnancy)

* Compensatory (liver after partial hepatectomy)

2. Pathologic2. Pathologic

Excessive hormone/GF stimulation of target tissue

* Endometrial hyperplasia (x’s estrogen)

* Benign prostatic hyperplasia (x’s androgens)

* Connective tissue cells in wound healing

Thyroid hyperplasia

HyperplasiaHyperplasia(Mechanism)

Cell proliferation

via increased production of TRANSCRIPTION FACTORS

due to

* Increased production of GF

* Increased levels of GF receptors

* Activation of intracellular signaling

Results in larger organ

AdaptedCell

2. Hypertrophy (larger cells)* Not due to swelling

* Increased synthesis of structural components

* Results in larger organ

* May occur with hyperplasia

HypertrophyComments

* Often involves switch from adult to fetal/neonatal forms i.e. -myosin heavy chain -myosin heavy chain

* Limited (can only increase so much)

Hypertrophy (Heart)

Hypertrophy of uterus

Normal HypertrophiedCardiac muscle hypertrophy

Hypertrophy (Mechanisms)

•Increased synthesis of structural proteins via

•Transcription factors (i. e. c-fos and c-jun)

•Growth factors (TGF-, IGF-1, FGF)

•Vasoactive agents (endothelien-1, AII)

Figure 1-4 Changes in the expression of selected genes and proteins during myocardial hypertrophy.

3. Atrophy (smaller cells)

1. Physiologic

During development: i.e. notochord; thyroglossal duct

2. Pathologic (local or generalized) via

* disuse * Loss of endocrine stimulation

* denervation * Aging

* ischemia * Pressure

* Nutrition

Normal Atrophied

Brain atrophy

Atrophy(Mechanism)

Reduction in structural components

Decreased number of mito, myofilaments, ER via

proteolysis (lysosomal proteases; ubiquitin-proteosome system)

Increase in number of autophagic vacuoles

Residual bodies (i.e. lipofuscin brown atrophy)

NB: diminished function but not dead

4. Metaplasia **One adult cell type replaces another**

Reversible

Columnar to squamous epithelium (most common epithelial type of metaplasia)

Chronic irritation i.e. (in trachea and bronchi of smokers)

Vit A deficiency squamous metaplasia in respiratory epithelium

May be some loss of function

May predispose to maligancy

Photomicrograph of the trachea from a smoker. Note that the columnar ciliated epithelium has been replaced by squamous epithelium.

Photomicrograph of the junction of normal epithelium (1) with hyperplastic

transitional epithelium (2).

Metaplasia(Mechanism)

Reprogramming

1. of stem cells present in normal tissues

2. of undifferentiated mesenchymal cells in connective tissue

Mediated by signals from

cytokines, GF or ECM

Leading to induction of specific transcription factors

Metaplasia versus Dysplasia

1. Dysplasia is a pathological term used to refer to an irregularity that hinders cell maturation within a particular tissue whereas Metaplasia is the process of the reversible substitution of a distinct kind of cell with another mature cell of the similar distinct kind.

2. Dysplasia is cancerous whereas Metaplasia is non-cancerous.

3. Metaplasia can be stopped by removing the abnormal stimulus, but Dysplasia is a non-reversible process.